Hjem › Lipoid nefrose › Michigan
Lipoid nefrose kliniske forsøg i Michigan
5 studier for Lipoid nefrose søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of Michigan Health System - Ann Arbor- Site Number : 8400010, Ann Arbor
RekruttererFase 2
Alder 16 til 75 · Alle køn · Opdateret 23. sep. 2026 · NCT06500702Nephrotic Syndrome Study Network
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererFase 2
Alder 1 til 17 · Alle køn · Opdateret 12. maj 2026 · NCT05003986Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
- University of Michigan, Ann Arbor
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 29. apr. 2026 · NCT05650619Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
- University of Michigan, Ann Arbor
RekruttererObservationsstudie
Alder 2 og opefter · Alle køn · Opdateret 22. dec. 2025 · NCT05505500Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.